Study finds no evidence for increased risk of thrombosis after Astrazeneca-vaccination
The British-Swedish pharmaceutical group Astrazeneca has launched a new study to its vaccine with positive results, according to which the vaccine is also effective in older people. There is an increased risk of thrombosis noted the researchers.
The Corona vaccine Astrazeneca is a large-scale study from the United States, however, also in the elderly is very effective and does not lead to an increased risk of thrombosis. As the British-Swedish pharmaceutical group announced on Monday that protects the vaccination, according to the new study data to 79 percent in front of a Corona infection with symptoms and to 100 percent in front of a severe course. In Germany and other European countries, trust in the vaccine was reduced according to a survey last.
In the Phase III study 32.449 subjects took part, therefore, is two-thirds of whom were vaccinated. About 20 percent of the participants were 65 years of age or older, and about 60 percent of pre-existing conditions such as Diabetes, increase the risk of a severe course of Covid-19-disease. There is an increased risk of thrombosis was not detected in the 21.583 subjects who received at least one Dose of the vaccine,.
The results of the study confirmed previous findings on the effectiveness of the Astrazeneca vaccine in adults, said the medical Professor Ann Falsey of the University of Rochester, which was involved in the study. For the first Time, comparable efficacy results in people over 65 years were but now.
Sharing for older people
According to the EU-wide approval of Astrazeneca vaccine by the end of December, Germany and other member countries had restricted the use first of all for people to 64 years of age, because older people do not have enough data templates. Until the beginning of March, Germany and other EU release countries of the Mediterranean, on the basis of new research data, but also for older people.
Following Reports of blood clots in temporal Association with Astrazeneca vaccinations Germany and many other countries had stopped the vaccination in mid-March, then. The EU medicines Agency (EMA) confirmed after further Review, but your assessment that the vaccine is “safe and effective”. Most of the countries received the vaccinations again.
After the turmoil confidence in Astrazeneca fell in several European countries, however, clearly. According to a survey conducted by the British Institute Yougov, a majority of people in Germany, France, Spain and Italy holds the vaccine was unsafe. Accordingly, the share of German, the distrust of the Astrazeneca compound increased, within one month to 15 percentage points to 55 percent. Only 32 percent of German citizens rated it as safe.
In France, 61 percent of the respondents were of the view that the Astrazeneca vaccine was not safe. This is especially evident suspicion rose in Spain and Italy, where the proportion of those referred to the vaccine as unsafe, increased by 27 percentage points. A completely different picture was in the UK, where, according to the survey, more than three-quarters of the citizens to the information that you keep the Astrazeneca vaccine for sure.
In the US, the vaccine Astrazeneca is not yet approved. The company announced plans to apply for on the basis of the new study data, now a Notzulassung in the United States.
Taiwan started with the vaccine of Astrazeneca on Monday its Corona vaccination campaign. Also the head of government Su Tseng-chang and health Minister Chen Shih-chung were vaccinated to advertise in the population for acceptance. So far, Astrazeneca has provided the only manufacturer in the doses according to Taiwan.